In Vivo Interleukin-13-Primed Macrophages Contribute to Reduced Alloantigen-Specific T Cell Activation and Prolong Immunological Survival of Allogeneic Mesenchymal Stem Cell Implants
Chloé J. Hoornaert, Evi Luyckx, Kristien Reekmans, Maxime Dhainaut, Caroline Guglielmetti, Debbie Le Blon, Dearbhaile Dooley, Erik Fransen, Jasmijn Daans, Louca Verbeeck, Alessandra Quarta, Nathalie De Vocht, Evi Lemmens, Herman Goossens, Annemie Van der Linden, Valerie D. Roobrouck, Catherine Verfaillie, Sven Hendrix, Muriel Moser, Zwi N. BernemanPeter Ponsaerts
Dive into the research topics of 'In Vivo Interleukin-13-Primed Macrophages Contribute to Reduced Alloantigen-Specific T Cell Activation and Prolong Immunological Survival of Allogeneic Mesenchymal Stem Cell Implants'. Together they form a unique fingerprint.